Patrick M. Skaggs
Research Subjects
Patrick M. Skaggs has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Claire L. Timlin
Four Rivers Kennel LLC, Walker, MO 64790, USA
2 shared publications - Sarah M. Dickerson
Four Rivers Kennel LLC, Walker, MO 64790, USA
2 shared publications - Craig N. Coon
Four Rivers Kennel , Walker, Missouri, 64790
1 shared publication - Craig Nelson Coon
Center of Excellence for Poultry Science, University of Arkansas, Fayetteville, Arkansas 72701, USA
1 shared publication - Fiona B. Mccracken
Four Rivers Kennel LLC, Walker, MO 64790, USA
1 shared publication - Jason W. Fowler
Four Rivers Kennel LLC, Walker, MO 64790, USA
1 shared publication
Latest Publications
- Open Access
Bifidobacterium animalis Subspecies lactis CECT 8145 Affects Markers of Metabolic Health in Dogs During Weight Gain and Weight Loss
This study explored the effects of Bifidobacterium animalis subspecies lactis CECT 8145 (B. animalis CECT 8145)—in both live probiotic and heat-treated postbiotic form—on metabolic health and digestion in male and female Labrador Retrievers during weight gain and loss. The study consisted of two, seven-week phases: weight gain (200% maintenance energy intake; Phase (1) and weight loss (100% maintenance energy requirement for ideal weight; Phase (2), separated by a 2-week washout period. In each phase, forty-five adult Labrador Retrievers (1.6–12.5 years) were randomly assigned to daily supplementation with live B. animalis CECT 8145 probiotic (PRO, n = 15), heat-treated B. animalis CECT 8145 postbiotic (POST, n = 15), or placebo control (CON, n = 15). Body weight, body condition score, fecal quality and food consumption were monitored throughout the study, and body composition, fecal, and blood samples were analyzed at the beginning and end of each phase. Digestibility was evaluated at the end of each phase. Post-prandial glucose responses were affected by intervention during weight loss, with a 6% reduction in the area under the curve (AUC) in POST compared to CON dogs (p = 0.035). Glucagon was decreased in females supplemented with POST (p = 0.0014), while POST males showed increased glucagon-like peptide-1 (GLP-1) compared to CON (p = 0.016) during weight gain. Serum GGT levels decreased, within the normal reference range, in POST compared to CON dogs during weight gain (post hoc p = 0.041). Fecal isovalerate was also reduced and fat digestibility increased (p = 0.026) in POST compared to CON (p = 0.018) during weight gain. There was a significant association between the group and gastric inhibitory polypeptide (GIP), with a decrease in GIP in POST over time (p = 0.030), and glucagon tended to be decreased in POST compared to CON (p = 0.073). Overall, these findings suggest supplementation with postbiotic B. animalis CECT 8145 may improve certain markers of Labrador retrievers’ metabolic health.
Open AccessBifidobacterium animalis Subspecies lactis CECT 8145 Affects Markers of Metabolic Health in Dogs During Weight Gain and Weight Loss
This study explored the effects of Bifidobacterium animalis subspecies lactis CECT 8145 (B. animalis CECT 8145)—in both live probiotic and heat-treated postbiotic form—on metabolic health and digestion in male and female Labrador Retrievers during weight gain and loss. The study consisted of two, seven-week phases: weight gain (200% maintenance energy intake; Phase (1) and weight loss (100% maintenance energy requirement for ideal weight; Phase (2), separated by a 2-week washout period. In each phase, forty-five adult Labrador Retrievers (1.6–12.5 years) were randomly assigned to daily supplementation with live B. animalis CECT 8145 probiotic (PRO, n = 15), heat-treated B. animalis CECT 8145 postbiotic (POST, n = 15), or placebo control (CON, n = 15). Body weight, body condition score, fecal quality and food consumption were monitored throughout the study, and body composition, fecal, and blood samples were analyzed at the beginning and end of each phase. Digestibility was evaluated at the end of each phase. Post-prandial glucose responses were affected by intervention during weight loss, with a 6% reduction in the area under the curve (AUC) in POST compared to CON dogs (p = 0.035). Glucagon was decreased in females supplemented with POST (p = 0.0014), while POST males showed increased glucagon-like peptide-1 (GLP-1) compared to CON (p = 0.016) during weight gain. Serum GGT levels decreased, within the normal reference range, in POST compared to CON dogs during weight gain (post hoc p = 0.041). Fecal isovalerate was also reduced and fat digestibility increased (p = 0.026) in POST compared to CON (p = 0.018) during weight gain. There was a significant association between the group and gastric inhibitory polypeptide (GIP), with a decrease in GIP in POST over time (p = 0.030), and glucagon tended to be decreased in POST compared to CON (p = 0.073). Overall, these findings suggest supplementation with postbiotic B. animalis CECT 8145 may improve certain markers of Labrador retrievers’ metabolic health.
- Open Access
Effects of a Saccharomyces cerevisiae-Derived Postbiotic in Adult Labrador Retrievers Undergoing Exercise and Transport Stress
Postbiotics are emerging as potential functional ingredients for companion animal diets. This study aimed to determine if a Saccharomyces cerevisiae-based postbiotic can alter cytokine and stress responses to exercise and transport stress in adult Labrador Retrievers. Dogs received 15 g ground corn germ (Control, n = 12), 7.5 g postbiotic (Low, n = 12), or 15 g postbiotic (High, n = 12), daily for 63 days. Exercise was twice weekly for 7 weeks, and a single transport per dog occurred in week 8. Fecal inflammatory biomarkers, serum chemistries, and complete blood counts were assessed at the beginning and end of the study. Serum cytokines were quantified before and 18–20 h after the first and last exercise runs. Gait analysis was assessed before and 24 h after the first and final runs. Saliva cortisol was measured before and after transportation. Treatment did not affect blood chemistries, gait, fecal biomarkers, or saliva cortisol (p ≥ 0.19). Eosinophils increased slightly in Controls (p = 0.01), though remained below 0.80 × 109 cells/L. Most cytokines were unaffected by treatment (p ≥ 0.15), but there were minor changes in circulating monocyte chemoattractant protein-1 (p = 0.01) and IL-8 over time at the initial run (p = 0.03) and IL-10 in males (p = 0.02) in the Low dose dogs. The High dose decreased Blautia (p = 0.04) slightly and tended to decrease Fusobacterium abundances (p = 0.07). The Low dose tended to increase Clostridium hiranonis (p = 0.07) slightly. The tested S. cerevisiae postbiotic produced small changes in immune function and gut microbial species in dogs.
Open AccessEffects of a Saccharomyces cerevisiae-Derived Postbiotic in Adult Labrador Retrievers Undergoing Exercise and Transport Stress
Postbiotics are emerging as potential functional ingredients for companion animal diets. This study aimed to determine if a Saccharomyces cerevisiae-based postbiotic can alter cytokine and stress responses to exercise and transport stress in adult Labrador Retrievers. Dogs received 15 g ground corn germ (Control, n = 12), 7.5 g postbiotic (Low, n = 12), or 15 g postbiotic (High, n = 12), daily for 63 days. Exercise was twice weekly for 7 weeks, and a single transport per dog occurred in week 8. Fecal inflammatory biomarkers, serum chemistries, and complete blood counts were assessed at the beginning and end of the study. Serum cytokines were quantified before and 18–20 h after the first and last exercise runs. Gait analysis was assessed before and 24 h after the first and final runs. Saliva cortisol was measured before and after transportation. Treatment did not affect blood chemistries, gait, fecal biomarkers, or saliva cortisol (p ≥ 0.19). Eosinophils increased slightly in Controls (p = 0.01), though remained below 0.80 × 109 cells/L. Most cytokines were unaffected by treatment (p ≥ 0.15), but there were minor changes in circulating monocyte chemoattractant protein-1 (p = 0.01) and IL-8 over time at the initial run (p = 0.03) and IL-10 in males (p = 0.02) in the Low dose dogs. The High dose decreased Blautia (p = 0.04) slightly and tended to decrease Fusobacterium abundances (p = 0.07). The Low dose tended to increase Clostridium hiranonis (p = 0.07) slightly. The tested S. cerevisiae postbiotic produced small changes in immune function and gut microbial species in dogs.